Antibodies Market 2027 By Product Type, Disease Indication, End User | The Insight Partners

Antibodies Market to 2027 - Global Analysis and Forecasts by Product Type (Monoclonal Antibodies, Polyclonal Antibodies, Antibody-drug Complexes) ; Disease Indication (Cardiovascular diseases, CNS disorders, Cancer, Autoimmune Disorders) ; End User (Hospital, Long term facilities, Research Institutes)

Report Code: TIPRE00005787 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
Antibodies or immunoglobulin are large Y-shaped protein that are produced primarily by plasma cells present in the blood ion response to pathogens such as viruses and bacteria. These are capable in identifying the unique molecules with harmful agents and are used in various therapeutics areas as well as during the diagnosis of diseases indications.

MARKET DYNAMICS
The Antibodies market is anticipated to grow in the forecast, owing to the factors such as high adoption of therapeutic antibodies in cost effective markets, innovation in products and novel product launches, and availability of inexpensive biosimilars therapeutic antibodies. Nevertheless, risk of side effects related to antibodies is expected to hamper the market growth during the forecast period.

MARKET SCOPE
The "Global Antibodies Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of Antibodies market with detailed market segmentation by product type, disease indication, end user and geography. The global Antibodies market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Antibodies market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Antibodies market is segmented on the basis of product type, disease indication and end user. Based on product type the market is segmented into monoclonal antibodies, polyclonal antibodies, antibody-drug complexes. Based on diseases indication the market is segmented into cardiovascular diseases, CNS Disorders, Cancer, autoimmune disorders. Based on end user the market is segmented into Hospitals, Long Term Care Facilities, Research Institutes.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Antibodies market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Antibodies market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Antibodies market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Antibodies market in these regions.

MARKET PLAYERS
The reports cover key developments in the Antibodies market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Antibodies market are anticipated to lucrative growth opportunities in the future with the rising demand for Antibodies market in the global market. Below mentioned is the list of few companies engaged in the Antibodies market.

The report also includes the profiles of Antibodies market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Eli Lilly and Company
  • AbbVie Inc
  • Bristol-Myers Squibb Company
  • Sanofi
  • Biogen
  • Takeda Pharmaceutical Company Limited
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc
  • Abgent
  • Novus Biologicals
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antibodies Market - By Product Type
1.3.2 Antibodies Market - By Disease Indication
1.3.3 Antibodies Market - By End User
1.3.4 Antibodies Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTIBODIES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIBODIES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIBODIES MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIBODIES - GLOBAL MARKET OVERVIEW
6.2. ANTIBODIES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIBODIES MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. MONOCLONAL ANTIBODIES
7.3.1. Overview
7.3.2. Monoclonal Antibodies Market Forecast and Analysis
7.4. POLYCLONAL ANTIBODIES
7.4.1. Overview
7.4.2. Polyclonal Antibodies Market Forecast and Analysis
7.5. ANTIBODY-DRUG COMPLEXES
7.5.1. Overview
7.5.2. Antibody-drug Complexes Market Forecast and Analysis
8. ANTIBODIES MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE INDICATION
8.1. OVERVIEW
8.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
8.3. CARDIOVASCULAR DISEASES
8.3.1. Overview
8.3.2. Cardiovascular diseases Market Forecast and Analysis
8.4. CNS DISORDERS
8.4.1. Overview
8.4.2. CNS disorders Market Forecast and Analysis
8.5. CANCER
8.5.1. Overview
8.5.2. Cancer Market Forecast and Analysis
8.6. AUTOIMMUNE DISORDERS
8.6.1. Overview
8.6.2. Autoimmune Disorders Market Forecast and Analysis
9. ANTIBODIES MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL
9.3.1. Overview
9.3.2. Hospital Market Forecast and Analysis
9.4. LONG TERM FACILITIES
9.4.1. Overview
9.4.2. Long term facilities Market Forecast and Analysis
9.5. RESEARCH INSTITUTES
9.5.1. Overview
9.5.2. Research Institutes Market Forecast and Analysis
10. ANTIBODIES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Antibodies Market Overview
10.1.2 North America Antibodies Market Forecasts and Analysis
10.1.3 North America Antibodies Market Forecasts and Analysis - By Product Type
10.1.4 North America Antibodies Market Forecasts and Analysis - By Disease Indication
10.1.5 North America Antibodies Market Forecasts and Analysis - By End User
10.1.6 North America Antibodies Market Forecasts and Analysis - By Countries
10.1.6.1 United States Antibodies Market
10.1.6.1.1 United States Antibodies Market by Product Type
10.1.6.1.2 United States Antibodies Market by Disease Indication
10.1.6.1.3 United States Antibodies Market by End User
10.1.6.2 Canada Antibodies Market
10.1.6.2.1 Canada Antibodies Market by Product Type
10.1.6.2.2 Canada Antibodies Market by Disease Indication
10.1.6.2.3 Canada Antibodies Market by End User
10.1.6.3 Mexico Antibodies Market
10.1.6.3.1 Mexico Antibodies Market by Product Type
10.1.6.3.2 Mexico Antibodies Market by Disease Indication
10.1.6.3.3 Mexico Antibodies Market by End User
10.2. EUROPE
10.2.1 Europe Antibodies Market Overview
10.2.2 Europe Antibodies Market Forecasts and Analysis
10.2.3 Europe Antibodies Market Forecasts and Analysis - By Product Type
10.2.4 Europe Antibodies Market Forecasts and Analysis - By Disease Indication
10.2.5 Europe Antibodies Market Forecasts and Analysis - By End User
10.2.6 Europe Antibodies Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Antibodies Market
10.2.6.1.1 Germany Antibodies Market by Product Type
10.2.6.1.2 Germany Antibodies Market by Disease Indication
10.2.6.1.3 Germany Antibodies Market by End User
10.2.6.2 France Antibodies Market
10.2.6.2.1 France Antibodies Market by Product Type
10.2.6.2.2 France Antibodies Market by Disease Indication
10.2.6.2.3 France Antibodies Market by End User
10.2.6.3 Italy Antibodies Market
10.2.6.3.1 Italy Antibodies Market by Product Type
10.2.6.3.2 Italy Antibodies Market by Disease Indication
10.2.6.3.3 Italy Antibodies Market by End User
10.2.6.4 Spain Antibodies Market
10.2.6.4.1 Spain Antibodies Market by Product Type
10.2.6.4.2 Spain Antibodies Market by Disease Indication
10.2.6.4.3 Spain Antibodies Market by End User
10.2.6.5 United Kingdom Antibodies Market
10.2.6.5.1 United Kingdom Antibodies Market by Product Type
10.2.6.5.2 United Kingdom Antibodies Market by Disease Indication
10.2.6.5.3 United Kingdom Antibodies Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Antibodies Market Overview
10.3.2 Asia-Pacific Antibodies Market Forecasts and Analysis
10.3.3 Asia-Pacific Antibodies Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Antibodies Market Forecasts and Analysis - By Disease Indication
10.3.5 Asia-Pacific Antibodies Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Antibodies Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Antibodies Market
10.3.6.1.1 Australia Antibodies Market by Product Type
10.3.6.1.2 Australia Antibodies Market by Disease Indication
10.3.6.1.3 Australia Antibodies Market by End User
10.3.6.2 China Antibodies Market
10.3.6.2.1 China Antibodies Market by Product Type
10.3.6.2.2 China Antibodies Market by Disease Indication
10.3.6.2.3 China Antibodies Market by End User
10.3.6.3 India Antibodies Market
10.3.6.3.1 India Antibodies Market by Product Type
10.3.6.3.2 India Antibodies Market by Disease Indication
10.3.6.3.3 India Antibodies Market by End User
10.3.6.4 Japan Antibodies Market
10.3.6.4.1 Japan Antibodies Market by Product Type
10.3.6.4.2 Japan Antibodies Market by Disease Indication
10.3.6.4.3 Japan Antibodies Market by End User
10.3.6.5 South Korea Antibodies Market
10.3.6.5.1 South Korea Antibodies Market by Product Type
10.3.6.5.2 South Korea Antibodies Market by Disease Indication
10.3.6.5.3 South Korea Antibodies Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Antibodies Market Overview
10.4.2 Middle East and Africa Antibodies Market Forecasts and Analysis
10.4.3 Middle East and Africa Antibodies Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Antibodies Market Forecasts and Analysis - By Disease Indication
10.4.5 Middle East and Africa Antibodies Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Antibodies Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Antibodies Market
10.4.6.1.1 South Africa Antibodies Market by Product Type
10.4.6.1.2 South Africa Antibodies Market by Disease Indication
10.4.6.1.3 South Africa Antibodies Market by End User
10.4.6.2 Saudi Arabia Antibodies Market
10.4.6.2.1 Saudi Arabia Antibodies Market by Product Type
10.4.6.2.2 Saudi Arabia Antibodies Market by Disease Indication
10.4.6.2.3 Saudi Arabia Antibodies Market by End User
10.4.6.3 U.A.E Antibodies Market
10.4.6.3.1 U.A.E Antibodies Market by Product Type
10.4.6.3.2 U.A.E Antibodies Market by Disease Indication
10.4.6.3.3 U.A.E Antibodies Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Antibodies Market Overview
10.5.2 South and Central America Antibodies Market Forecasts and Analysis
10.5.3 South and Central America Antibodies Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Antibodies Market Forecasts and Analysis - By Disease Indication
10.5.5 South and Central America Antibodies Market Forecasts and Analysis - By End User
10.5.6 South and Central America Antibodies Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Antibodies Market
10.5.6.1.1 Brazil Antibodies Market by Product Type
10.5.6.1.2 Brazil Antibodies Market by Disease Indication
10.5.6.1.3 Brazil Antibodies Market by End User
10.5.6.2 Argentina Antibodies Market
10.5.6.2.1 Argentina Antibodies Market by Product Type
10.5.6.2.2 Argentina Antibodies Market by Disease Indication
10.5.6.2.3 Argentina Antibodies Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANTIBODIES MARKET, KEY COMPANY PROFILES
12.1. ELI LILLY AND COMPANY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ABBVIE INC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BRISTOL-MYERS SQUIBB COMPANY
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. SANOFI
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BIOGEN
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. TAKEDA PHARMACEUTICAL COMPANY LIMITED
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. F. HOFFMANN-LA ROCHE LTD
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. THERMO FISHER SCIENTIFIC INC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ABGENT
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. NOVUS BIOLOGICALS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

- Eli Lilly and Company
- AbbVie Inc
- Bristol-Myers Squibb Company
- Sanofi
- Biogen
- Takeda Pharmaceutical Company Limited
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc
- Abgent
- Novus Biologicals